Roles of PFKFB3 in cancer (Q89700549)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

review article

1 reference

title

Roles of PFKFB3 in cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Linlin Shi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Hongming Pan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Zhen Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Jiansheng Xie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Weidong Han

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

publication date

24 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

page(s)

17044

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

7 April 2020

start time

24 November 2017

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Enzymology of cancer cells (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: suiting structure to need, in a family of tissue-specific enzymes.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Characterization of a Human Placental Fructose-6-Phosphate, 2-Kinase/Fructose- 2,6 - Bisphosphatase

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

LOH on 10p14‐p15 targets the PFKFB3 gene locus in human glioblastomas

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Evolutionary Reengineering of the Phosphofructokinase Active Site: ARG-104 Does Not Stabilize the Transition State in 6-Phosphofructo-2-Kinase

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Ras transformation requires metabolic control by 6-phosphofructo-2-kinase

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Increased concentrations of fructose 2,6-bisphosphate contribute to the Warburg effect in phosphatase and tensin homolog (PTEN)-deficient cells.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The transcriptional co-repressor myeloid translocation gene 16 inhibits glycolysis and stimulates mitochondrial respiration

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Progestins activate 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

PFKFB3 Control of Cancer Growth by Responding to Circadian Clock Outputs

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Insulin induces PFKFB3 gene expression in HT29 human colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Interleukin 6 enhances glycolysis through expression of the glycolytic enzymes hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Cooperation of adenosine with macrophage Toll-4 receptor agonists leads to increased glycolytic flux through the enhanced expression of PFKFB3 gene.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

AU-rich elements: characterization and importance in mRNA degradation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

A common phosphorylation site for cyclic AMP-dependent protein kinase and protein kinase C in human placental 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-beta-TrCP, sequentially regulate glycolysis during the cell cycle.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

MAPK14/p38α-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

p27Kip1 overexpression causes apoptotic death of mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Rat hepatoma (HTC) cell 6-phosphofructo-2-kinase differs from that in liver and can be separated from fructose-2,6-bisphosphatase

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Glucose regulation of gene transcription

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Cancer stem cells: an old idea--a paradigm shift

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

EMT and dissemination precede pancreatic tumor formation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Tumour stem cells and drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Cancer stem cell theory and the warburg effect, two sides of the same coin?

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The secretome of colon cancer stem cells contains drug-metabolizing enzymes

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Akt inhibition attenuates rasfonin-induced autophagy and apoptosis through the glycolytic pathway in renal cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

PFKFB3 was overexpressed in gastric cancer patients and promoted the proliferation and migration of gastric cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Molecular definition of breast tumor heterogeneity

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The expression pattern of PFKFB3 enzyme distinguishes between induced-pluripotent stem cells and cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Coordinating cell behaviour during blood vessel formation.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Basic and Therapeutic Aspects of Angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Role of PFKFB3-driven glycolysis in vessel sprouting

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Metabolic properties of freshly isolated bovine endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Why do cancers have high aerobic glycolysis?

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Prognostic value of microvessel density in invasive ductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Dll4-Notch signaling in regulation of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. II. Relative importance of glycolysis and oxidative phosphorylation on phytohaemagglutinin stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Signaling takes a breath--new quantitative perspectives on bioenergetics and signal transduction.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Revving the engine: signal transduction fuels T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Posttranscriptional control of T cell effector function by aerobic glycolysis

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Interferons, immunity and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Fueling immunity: insights into metabolism and lymphocyte function

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Inflammatory bowel disease as a risk factor for colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Hypersensitization of tumor cells to glycolytic inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3).

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Structure-Based Development of Small Molecule PFKFB3 Inhibitors: A Framework for Potential Cancer Therapeutic Agents Targeting the Warburg Effect

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Precise Engineering of Prodrug Cocktails into Single Polymeric Nanoparticles for Combination Cancer Therapy: Extended and Sequentially Controllable Drug Release

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Block copolymer micelles for controlled delivery of glycolytic enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Lipid metabolism in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The fat side of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation

1 reference

https://api.crossref.org/works/10.1038%2FSIGTRANS.2017.44

7 January 2021

Glu327 is part of a catalytic triad in rat liver fructose-2,6-bisphosphatase

1 reference

12 December 2020

Hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. The role of surface loop basic residues in substrate binding to the fructose-2,6-bisphosphatase domain

1 reference

12 December 2020

Hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Use of site-directed mutagenesis to evaluate the roles of His-258 and His-392 in catalysis

1 reference

12 December 2020

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

Regulation of rat liver fructose 2,6-bisphosphatase

1 reference

12 December 2020

High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers

1 reference

12 December 2020

Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death

1 reference

12 December 2020

Inflammation in cancer: a therapeutic target?

1 reference

12 December 2020

Structure-based rational design of prodrugs to enable their combination with polymeric nanoparticle delivery platforms for enhanced antitumor efficacy.

1 reference

12 December 2020

Inhibition of Growth of Bladder Cancer Cells by 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one in Combination with Other Compounds Affecting Glucose Metabolism.

1 reference

12 December 2020

Inhibition of Growth by Combined Treatment with Inhibitors of Lactate Dehydrogenase and either Phenformin or Inhibitors of 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase 3.

1 reference

12 December 2020

Identifiers

DOI

10.1038/SIGTRANS.2017.44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

PubMed publication ID

29263928

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29263928%20AND%20SRC:MED&resulttype=core&format=json